These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9583749)

  • 1. Molecular basis of non-lethal junctional epidermolysis bullosa: identification of a 38 basepair insertion and a splice site mutation in exon 14 of the LAMB3 gene.
    Cserhalmi-Friedman PB; Baden H; Burgeson RE; Christiano AM
    Exp Dermatol; 1998; 7(2-3):105-11. PubMed ID: 9583749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A homozygous nonsense mutation in the alpha 3 chain gene of laminin 5 (LAMA3) in lethal (Herlitz) junctional epidermolysis bullosa.
    Kivirikko S; McGrath JA; Baudoin C; Aberdam D; Ciatti S; Dunnill MG; McMillan JR; Eady RA; Ortonne JP; Meneguzzi G
    Hum Mol Genet; 1995 May; 4(5):959-62. PubMed ID: 7633458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compound heterozygosity for nonsense ans missense mutations in the LAMB3 gene in nonlethal junctional epidermolysis bullosa.
    McGarth JA; Christiano AM; Pulkkinen L; Eady RA; Uitto J
    J Invest Dermatol; 1996 May; 106(5):1157-9. PubMed ID: 8618058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compound heterozygosity for nonsense and missense mutations in the LAMB3 gene in nonlethal junctional epidermolysis bullosa.
    Christiano AM; Pulkkinen L; Eady RA; Uitto J
    J Invest Dermatol; 1996 Apr; 106(4):775-7. PubMed ID: 8618020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laminin 5 mutations in junctional epidermolysis bullosa: molecular basis of Herlitz vs. non-Herlitz phenotypes.
    Nakano A; Chao SC; Pulkkinen L; Murrell D; Bruckner-Tuderman L; Pfendner E; Uitto J
    Hum Genet; 2002 Jan; 110(1):41-51. PubMed ID: 11810295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant splicing as potential modifier of the phenotype of junctional epidermolysis bullosa.
    Mittwollen R; Wohlfart S; Park J; Grosch E; Has C; Hohenester E; Schneider H; Hammersen J
    J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):2127-2134. PubMed ID: 32124492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predominance of the recurrent mutation R635X in the LAMB3 gene in European patients with Herlitz junctional epidermolysis bullosa has implications for mutation detection strategy.
    Pulkkinen L; Meneguzzi G; McGrath JA; Xu Y; Blanchet-Bardon C; Ortonne JP; Christiano AM; Uitto J
    J Invest Dermatol; 1997 Aug; 109(2):232-7. PubMed ID: 9242513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel compound heterozygous mutation in LAMC2 genes (c.79G>A and 382insT) in Herlitz junctional epidermolysis bullosa.
    Jeon IK; Kim SE; Kim SC
    J Dermatol; 2014 Apr; 41(4):322-4. PubMed ID: 24533970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered laminin 5 expression due to mutations in the gene encoding the beta 3 chain (LAMB3) in generalized atrophic benign epidermolysis bullosa.
    McGrath JA; Pulkkinen L; Christiano AM; Leigh IM; Eady RA; Uitto J
    J Invest Dermatol; 1995 Apr; 104(4):467-74. PubMed ID: 7706760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of the human laminin alpha3a chain gene (LAMA3a): a strategy for mutation identification and DNA-based prenatal diagnosis in Herlitz junctional epidermolysis bullosa.
    Pulkkinen L; Cserhalmi-Friedman PB; Tang M; Ryan MC; Uitto J; Christiano AM
    Lab Invest; 1998 Sep; 78(9):1067-76. PubMed ID: 9759651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the gamma 2 chain gene (LAMC2) of kalinin/laminin 5 in the junctional forms of epidermolysis bullosa.
    Pulkkinen L; Christiano AM; Airenne T; Haakana H; Tryggvason K; Uitto J
    Nat Genet; 1994 Mar; 6(3):293-7. PubMed ID: 8012393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of novel LAMC2 mutations in Herlitz junctional epidermolysis Bullosa.
    Pulkkinen L; McGrath J; Airenne T; Haakana H; Tryggvason K; Kivirikko S; Meneguzzi G; Ortonne JP; Christiano AM; Uitto J
    Mol Med; 1997 Feb; 3(2):124-35. PubMed ID: 9085255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moderation of phenotypic severity in dystrophic and junctional forms of epidermolysis bullosa through in-frame skipping of exons containing non-sense or frameshift mutations.
    McGrath JA; Ashton GH; Mellerio JE; Salas-Alanis JC; Swensson O; McMillan JR; Eady RA
    J Invest Dermatol; 1999 Sep; 113(3):314-21. PubMed ID: 10469327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A homozygous nonsense mutation in the beta 3 chain gene of laminin 5 (LAMB3) in Herlitz junctional epidermolysis bullosa.
    Pulkkinen L; Christiano AM; Gerecke D; Wagman DW; Burgeson RE; Pittelkow MR; Uitto J
    Genomics; 1994 Nov; 24(2):357-60. PubMed ID: 7698759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA based molecular analysis in the rapid diagnosis of Herlitz junctional epidermolysis bullosa.
    Cserhalmi-Friedman PB; Yeboa KA; Christiano AM
    Clin Exp Dermatol; 2001 Mar; 26(2):205-7. PubMed ID: 11298117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herlitz junctional epidermolysis bullosa: diagnostic features, mutational profile, incidence and population carrier frequency in the Netherlands.
    Yuen WY; Lemmink HH; van Dijk-Bos KK; Sinke RJ; Jonkman MF
    Br J Dermatol; 2011 Dec; 165(6):1314-22. PubMed ID: 21801158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laminin-5 mutational analysis in an Italian cohort of patients with junctional epidermolysis bullosa.
    Posteraro P; De Luca N; Meneguzzi G; El Hachem M; Angelo C; Gobello T; Tadini G; Zambruno G; Castiglia D
    J Invest Dermatol; 2004 Oct; 123(4):639-48. PubMed ID: 15373767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compound heterozygosity for an out-of-frame deletion and a splice site mutation in the LAMB3 gene causes nonlethal junctional epidermolysis bullosa.
    Posteraro P; Sorvillo S; Gagnoux-Palacios L; Angelo C; Paradisi M; Meneguzzi G; Castiglia D; Zambruno G
    Biochem Biophys Res Commun; 1998 Feb; 243(3):758-64. PubMed ID: 9501007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of K140 immunoreactivity in junctional epidermolysis bullosa skin and keratinocytes associates with misfolded laminin epidermal growth factor-like motif 2 of the β3 short arm.
    Condorelli AG; Fortugno P; Cianfarani F; Proto V; Di Zenzo G; Didona B; Zambruno G; Castiglia D
    Br J Dermatol; 2018 Jun; 178(6):1416-1422. PubMed ID: 28561256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laminin 5 genes and Herlitz junctional epidermolysis bullosa: novel mutations and polymorphisms in the LAMB3 and LAMC2 genes. Mutations in brief no. 190. Online.
    Kon A; Pulkkinen L; Hara M; Tamai K; Tagami H; Hashimoto I; Uitto J
    Hum Mutat; 1998; 12(4):288. PubMed ID: 10660342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.